Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Perfect

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Antimicrobial Agents and Chemotherapy|November 14, 2018
Population Pharmacodynamics of Amphotericin B Deoxycholate for Disseminated Infection Caused by <i>Talaromyces marneffei</i>Thuy Le, Vo Trieu Ly, Nguyen Thi Mai Thu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 24, 2020
Cryptococcal Antigen in Serum and Cerebrospinal Fluid for Detecting Cryptococcal Meningitis in Adults Living With Human Immunodeficiency Virus: Systematic Review and Meta-Analysis of Diagnostic Test Accuracy StudiesElvis Temfack, Jean Joel Bigna Rim, Rene Spijker, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2025
In Vitro Evidence to Support Amphotericin B and Flucytosine Combination Therapy for TalaromycosisHeera Natesan Sambath, Shawin Vitsupakorn, Kaushik Sreerama Reddy, et al.
Plos Neglected Tropical Diseases|December 31, 2025
In vitro evidence to support amphotericin B and flucytosine combination therapy for talaromycosisHeera Natesan Sambath, Shawin Vitsupakorn, Kaushik Sreerama Reddy, et al.
The New England Journal of Medicine|January 26, 2007
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropeniaOliver A Cornely, Johan Maertens, Drew J Winston, et al.
Antimicrobial Agents and Chemotherapy|July 23, 2014
Phase 1b study of new posaconazole tablet for prevention of invasive fungal infections in high-risk patients with neutropeniaRafael F Duarte, Javier López-Jiménez, Oliver A Cornely, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 15, 2023
Description of Cryptococcosis Following SARS-CoV-2 Infection: A Disease Survey Through the Mycosis Study Group Education and Research Consortium (MSG-19)Jeremey Walker, Todd McCarty, Gerald McGwin, et al.
The Lancet. HIV|October 12, 2023
HIV and fungal priority pathogensHatim Sati, Ana Alastruey-Izquierdo, John Perfect, et al.
Medical Mycology|June 27, 2024
Cryptococcosis-a systematic review to inform the World Health Organization Fungal Priority Pathogens ListAiken Dao, Hannah Yejin Kim, Katherine Garnham, et al.
Scandinavian Journal of Infectious Diseases|August 17, 2004
Candida endocarditis: contemporary cases from the International Collaboration of Infectious Endocarditis Merged Database (ICE-mD)Daniel K Benjamin, Jose M Miro, Bruno Hoen, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Antimicrobial Agents and Chemotherapy|November 14, 2018
Population Pharmacodynamics of Amphotericin B Deoxycholate for Disseminated Infection Caused by <i>Talaromyces marneffei</i>Thuy Le, Vo Trieu Ly, Nguyen Thi Mai Thu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 24, 2020
Cryptococcal Antigen in Serum and Cerebrospinal Fluid for Detecting Cryptococcal Meningitis in Adults Living With Human Immunodeficiency Virus: Systematic Review and Meta-Analysis of Diagnostic Test Accuracy StudiesElvis Temfack, Jean Joel Bigna Rim, Rene Spijker, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2025
In Vitro Evidence to Support Amphotericin B and Flucytosine Combination Therapy for TalaromycosisHeera Natesan Sambath, Shawin Vitsupakorn, Kaushik Sreerama Reddy, et al.
Plos Neglected Tropical Diseases|December 31, 2025
In vitro evidence to support amphotericin B and flucytosine combination therapy for talaromycosisHeera Natesan Sambath, Shawin Vitsupakorn, Kaushik Sreerama Reddy, et al.
The New England Journal of Medicine|January 26, 2007
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropeniaOliver A Cornely, Johan Maertens, Drew J Winston, et al.
Antimicrobial Agents and Chemotherapy|July 23, 2014
Phase 1b study of new posaconazole tablet for prevention of invasive fungal infections in high-risk patients with neutropeniaRafael F Duarte, Javier López-Jiménez, Oliver A Cornely, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 15, 2023
Description of Cryptococcosis Following SARS-CoV-2 Infection: A Disease Survey Through the Mycosis Study Group Education and Research Consortium (MSG-19)Jeremey Walker, Todd McCarty, Gerald McGwin, et al.
The Lancet. HIV|October 12, 2023
HIV and fungal priority pathogensHatim Sati, Ana Alastruey-Izquierdo, John Perfect, et al.
Medical Mycology|June 27, 2024
Cryptococcosis-a systematic review to inform the World Health Organization Fungal Priority Pathogens ListAiken Dao, Hannah Yejin Kim, Katherine Garnham, et al.
Scandinavian Journal of Infectious Diseases|August 17, 2004
Candida endocarditis: contemporary cases from the International Collaboration of Infectious Endocarditis Merged Database (ICE-mD)Daniel K Benjamin, Jose M Miro, Bruno Hoen, et al.
Pageof 5